Prescription drug · NDA
Lovenox (enoxaparin sodium) NDC 55154-4028
Enoxaparin sodium 40 mg/.4mL · Injection · Subcutaneous · Cardinal Health 107, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55154-4028-5 | 55154402805 | 5 SYRINGE in 1 BAG (55154-4028-5) / .4 mL in 1 SYRINGEMarketed from Mar 29, 1993 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lovenox
- Generic name (nonproprietary)
- enoxaparin sodium
- Active ingredients
- Enoxaparin sodium — 40 mg/.4mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Labeler
- Cardinal Health 107, LLC
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020164
- Marketing start
- Listing expires
- Other FDA classes
- Low-Molecular-Weight (Chemical structure)
- Identifiers
- Product ID 55154-4028_ebd70650-9a1a-4922-859c-d14448c43c70SPL ID ebd70650-9a1a-4922-859c-d14448c43c70SPL set ID 3d263380-4f44-4fd8-aa2a-e69702ab258fRxCUI 854235, 854236UNII 8NZ41MIK1OUPC 0055154402859
- Pharmacologic class
- Low Molecular Weight Heparin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N455154402805followed by a unit qualifier and the quantityPackage 55154-4028-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under NDA 020164
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lovenoxenoxaparin sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-2915 |
| Enoxaparin sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1010 |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-605 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-0622 |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-605 |
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-609 |
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-607 |
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-607 |
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-609 |
| Enoxaparin sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1004 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-8014 |
| Enoxaparin sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1006 |
| Enoxaparin sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1008 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-0620 |
| Enoxaparin sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1012 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-8025 |
| Enoxaparin sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1015 |
| Enoxaparin sodium | Enoxaparin sodium 300 mg/3mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1016 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | Sanofi-Aventis U.S. LLC | 0075-0626 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-8020 |
Showing 20 of 39.